1 not yet recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Thymic epithelial tumor: new trials by email Literature Review of Thymic epithelial tumor trials Research Report on Thymic epithelial tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors Cyclophosphamide, Doxorubicin, and Cisplatin (CAP), nab-Paclitaxel and Carboplatin - Thymoma and Thymic Carcinoma | Phase 2 / Phase 3 | Not yet recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 116 | 2026-03-01 | 2026-03-11 |
Mediastinal Neoplasms (1) · Thymoma (1)
Hemic and Lymphatic Diseases (1) · Lymphatic Diseases (1) · Mediastinal Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Complex and Mixed (1) · Respiratory Tract Diseases (1) · Thoracic Diseases (1) · Thoracic Neoplasms (1) · Thymus Neoplasms (1)
130-nm albumin-bound paclitaxel (1) · Carboplatin (1) · Cisplatin (1) · Cyclophosphamide (1) · Doxorubicin (1)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)
China (1)